Stand Up To Cancer’s (SU2C) mission is to raise funds to accelerate the pace of groundbreaking translational research that can get new therapies to patients quickly and save lives now.
SU2C brings together the best and the brightest researchers and mandates collaboration among the cancer community. By galvanizing the entertainment industry, SU2C has set out to generate awareness, educate the public on cancer prevention and help more people diagnosed with cancer become long-term survivors.
Here we stand, on the verge of unlocking the answers that will finally conquer cancer.
Cancer takes one person every minute. One life in a moment. They are our brothers, our sisters, our fathers and mothers, our husbands and wives, our best friends, our children, ourselves. Every day in America, 1,670 people die despite the fact that the means to save them are literally within our reach. To wait any longer for someone else to save our lives and the lives of those we love is unforgivable. We must act now.
For the first time in history, we can envision the possibility of stopping cancer in its tracks. Now more than ever, as government funding for cancer research is disappearing from the national agenda, every single one of us affected by cancer must stand up and be heard.
Working with the top experts in cancer research, Stand Up To Cancer is forging a new way to develop breakthroughs that will end cancer. We’re putting together the best and the brightest minds in cancer research, investing in their projects and taking the bureaucratic obstacles out of their way. SU2C’s interdisciplinary Dream Teams of scientists, clinicians, technicians and other experts, are hard at work on solutions to the unique problems that cancer presents. Learn More.
SU2C’s funding is administered by the American Association for Cancer Research, the largest scientific organization in the world focusing on every aspect of high-quality, innovative cancer research. Together with Stand Up To Cancer’s “Blue Ribbon” Scientific Advisory Council, comprised of world-class scientists across several disciplines and patient advocates, the most promising projects are identified, mentored, and funded.
We now understand the very biology that drives cancer. With knowledge gained from the mapping of the human genome, we can target the genes and pathways that are involved in turning normal cells into cancerous ones. We are on the brink of possessing a toolbox full of new, advanced therapies just waiting to be adapted to benefit patients. Right before us, so close we can almost touch them, are scientific breakthroughs in the prevention, detection, treatment - and even reversal - of this disease.
This is where the end of cancer begins: when we unite in one movement, unstoppable.